ECIA Stock Overview
A medical device company, designs, develops, manufactures, and markets patented surgical instruments in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Encision Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.36 |
| 52 Week High | US$0.75 |
| 52 Week Low | US$0.12 |
| Beta | 0.54 |
| 11 Month Change | -28.50% |
| 3 Month Change | -28.50% |
| 1 Year Change | -10.63% |
| 33 Year Change | -64.25% |
| 5 Year Change | 5.15% |
| Change since IPO | -96.60% |
Recent News & Updates
Recent updates
Shareholder Returns
| ECIA | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -14.9% | 0.4% | 0.4% |
| 1Y | -10.6% | -0.6% | 22.9% |
Return vs Industry: ECIA underperformed the US Medical Equipment industry which returned -0.5% over the past year.
Return vs Market: ECIA underperformed the US Market which returned 23.3% over the past year.
Price Volatility
| ECIA volatility | |
|---|---|
| ECIA Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 7.7% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in US Market | 15.5% |
| 10% least volatile stocks in US Market | 2.9% |
Stable Share Price: ECIA's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine ECIA's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1991 | 32 | Greg Trudel | www.encision.com |
Encision Inc., a medical device company, designs, develops, manufactures, and markets patented surgical instruments in the United States. The company provides active electrode monitoring (AEM) surgical instruments and monitors that enhance patient safety and patient outcomes in laparoscopic surgical procedures. Its AEM instruments product line comprises a range of endo-mechanical instruments, including scissors, graspers, and dissectors, as well as fixed-tip electrodes and suction-irrigation electrodes.
Encision Inc. Fundamentals Summary
| ECIA fundamental statistics | |
|---|---|
| Market cap | US$4.99m |
| Earnings (TTM) | -US$448.00k |
| Revenue (TTM) | US$6.87m |
0.6x
P/S Ratio-9.5x
P/E RatioIs ECIA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ECIA income statement (TTM) | |
|---|---|
| Revenue | US$6.87m |
| Cost of Revenue | US$3.40m |
| Gross Profit | US$3.47m |
| Other Expenses | US$3.92m |
| Earnings | -US$448.00k |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.038 |
| Gross Margin | 50.54% |
| Net Profit Margin | -6.52% |
| Debt/Equity Ratio | 12.7% |
How did ECIA perform over the long term?
See historical performance and comparison